# Coral Pharmaceuticals LTD – FDA Inspection, May 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/coral-pharmaceuticals-ltd/4c3e06d3-9482-4b37-ae0c-136a9c41e507
Source feed: FDA_Inspections

> FDA inspection 1090617 of Coral Pharmaceuticals LTD, May 24, 2019. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090617
- Company Name: Coral Pharmaceuticals LTD
- Inspection Date: 2019-05-24
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6
- Enforcement Type: WARNING_LETTER

## Related Officers

- [Kenneth H. Williams](https://www.keypedia.com/people/kenneth-h-williams/20a225cd-a3d5-478f-ae04-2a8e119df8a6)
- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/coral-pharmaceuticals-ltd/24ae84dc-a870-4b26-96c3-163b4e8c263f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c